The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Trump says US and Tehran having 'good talks'
Israel to allow international force into Gaza, Israeli official says
Saudi Arabia reaffirms right to defend its security against drone attacks
UK's Burnham welcomes Zelenskyy as first foreign visitor
Philippines' Marcos puts anti-graft campaign at centre of address to Congress
